Similar articles

• Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

  Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R; Portal Hypertension Collaborative Group. Groszmann RJ, et al. N Engl J Med. 2005 Nov 24;353(21):2254-61. doi: 10.1056/NEJMoa044456. N Engl J Med. 2005. PMID: 16306522 Clinical Trial.
• Preventing the development of varices in cirrhosis.

  Garcia-Tsao G. Garcia-Tsao G. J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S300-4. doi: 10.1097/MCG.0b013e318157c63d. J Clin Gastroenterol. 2007. PMID: 17975480 Clinical Trial.
• Beta-blockers to prevent gastroesophageal varices in cirrhosis.

  Post AB. Post AB. N Engl J Med. 2006 Mar 23;354(12):1318-20; author reply 1318-20. doi: 10.1056/NEJMc053519. N Engl J Med. 2006. PMID: 16554538 No abstract available.
• Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.

  Zoller WG, Gross M. Zoller WG, et al. Eur J Med Res. 1996 Jun 25;1(9):407-16. Eur J Med Res. 1996. PMID: 9353240 Review.
• Management of varices and variceal hemorrhage in cirrhosis.

  Garcia-Tsao G, Bosch J. Garcia-Tsao G, et al. N Engl J Med. 2010 Mar 4;362(9):823-32. doi: 10.1056/NEJMra0901512. N Engl J Med. 2010. PMID: 20200386 Review. No abstract available.